T.Man Pharmaceutical PCL (BKK:TMAN)

Thailand flag Thailand · Delayed Price · Currency is THB
12.50
-0.10 (-0.79%)
Last updated: Mar 4, 2026, 3:37 PM ICT
Market Cap5.04B -13.1%
Revenue (ttm)2.53B +13.5%
Net Income523.07M +16.1%
EPS1.31 -0.4%
Shares Out400.00M
PE Ratio9.64
Forward PE9.69
Dividend0.32 (2.54%)
Ex-Dividend DateMay 8, 2026
Volume759,366
Average Volume480,422
Open12.30
Previous Close12.60
Day's Range11.80 - 12.50
52-Week Range9.90 - 13.60
Betan/a
RSI62.99
Earnings DateFeb 25, 2026

About T.Man Pharmaceutical PCL

T.Man Pharmaceutical Public Company Limited manufactures and sells pharmaceuticals and health care products in Thailand. The company operates through three segments: Manufactured Products Under Own Brand, Manufactured Products Under Third Parties’ Brand, and Trading Products. It offers antibacterial, central nervous system, corticosteroid, chronic diseases, gastrointestinal, respiratory, and musculoskeletal drugs, as well as medical devices, vaginal suppositories, dermatological, mouth, and throat products. The company also provides herbal and ... [Read more]

Sector Healthcare
Founded 1991
Employees 944
Stock Exchange Stock Exchange of Thailand
Ticker Symbol TMAN
Full Company Profile

Financial Performance

In 2025, T.Man Pharmaceutical PCL's revenue was 2.53 billion, an increase of 13.48% compared to the previous year's 2.23 billion. Earnings were 523.07 million, an increase of 16.06%.

Financial Statements